Stock Analyst Alerts: Rambus, Hartford Financial, Freeport-McMoRan, Watson Pharmaceuticals, Catalyst Health Solutions (RMBS,HIG,FCX,WPI,CHSI)
Rambus Inc.(NASDAQ:RMBS): BWS Financial believes Rambus’ (NASDAQ:RMBS) settlement with NVIDA (NASDAQ:NVDA) is a significant positive surprise since it brings an end to a costly legal battle for the company. The firm is surprised by the minimal upside reaction to Rambus shares and recommends buying the stock at current levels.
Hartford Financial Services Group Inc.(NYSE:HIG): After listening to Hartford Financial on its earnings call, Wells Faro believes splitting the company up is not management’s top priority. Wells thinks a split-up strategy or one of growth will take time to exeucte and keeps a Market Perform rating on Hartford Financial shares.
Freeport-McMoRan Copper & Gold Inc.(NYSE:FCX): Freeport McMoRan removed from short-term buy list at Deutsche Bank
Watson Pharmaceuticals Inc.(NYSE:WPI): Barclays believes Watson Pharamceuticals and Endo are likely to settle in their Lidoderm trial which is scheduled to finish by mid-day Friday. Shares of Watson are Overweight rated.
Catalyst Health Solutions, Inc.(NASDAQ:CHSI): Citigroup said the Maryland Board of Public works confirmed a prior decision to select Express Scripts (NASDAQ:ESRX) for the State Employee PBM contract. The firm said the contract was already removed from its Catalyst Health (NASDAQ:CHSI) estimates and maintains its Buy rating.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com